Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Covance Seeks Outside Investor For Expansion Of Biomanufacturing Business

Executive Summary

Covance is seeking a third-party investment of several hundred million dollars to expand its commercial biomanufacturing business to meet growing demand.

You may also be interested in...

Novartis Reduces Outsourcing Through Parexel; CRO To Lay Off 400-500

Novartis' cancellation of several outsourcing contracts with Parexel could result in a reduction of the contract research organization's workforce by 400-500 positions, Parexel said.

Centocor Retavase

Covance will manufacture reteplase for U.S. and Canadian supply under a long-term contract. The fibrinolytic will be produced at Covance's new Research Triangle Park, N.C. facility. Previously Roche produced Retevase; Centocor purchased the product at the time of the 1997 Roche/Corange merger to prevent an antitrust conflict with Roche affiliate Genentech's Activase (alteplase)

Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data

Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts